With evidence-based smartphone apps developed by our Center for Behavioral Intervention Technologies, mental healthcare is always within reach.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
In recent Northwestern Medicine clinical trials, an experimental drug improved survival rates for patients with advanced midgut neuroendocrine tumors compared to a standard therapy.
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
When Major League Baseball players travel in a way that misaligns their internal 24-hour clock with the natural environment and its cycle of sunlight, they suffer negative consequences, according to a recent study.
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
Children with congenital heart disease have a higher risk of epilepsy through adulthood, according to a recent Northwestern Medicine study.
Notifications